Armata Pharmaceuticals, Inc. — Director's Dealing 2021

Mar 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Armata Pharmaceuticals, Inc. (ARMP)
CIK: 0000921114
Period of Report: 2021-03-17

Reporting Person: Innoviva, Inc. (Director, 10% Owner)
Reporting Person: Innoviva Strategic Opportunities LLC (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-17	Common Stock	P	4285935	$3.25	Acquired	6153847	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-17	Warrants to Purchase Common Stock	$3.25	P	4285935	Acquired	2026-03-17	Common Stock (4285935)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8710800	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants to Purchase Common Stock	$2.87		Common Stock ()	8710800	Direct

Footnotes

F1: See Ex. 99.1.

F2: See Ex. 99.1.

F3: See Ex. 99.1.